uTR
uTR decomposes mosaic tandem repeats (TRs) from long-read sequencing data to enable accurate characterization of complex repeat architectures associated with diseases, including brain disorders.
Key Features:
- Algorithm: Uses an efficient algorithm specifically tailored to decompose mosaic tandem repeats with high sensitivity.
- Input data: Operates on long-read sequencing data to detect extended and complex TR structures.
- Mosaic TR resolution: Resolves mosaic TRs that comprise multiple distinct repeat units rather than single homogeneous repeats.
- Comparative accuracy: Demonstrates superior prediction accuracy compared with TRF (Tandem Repeats Finder) and RepeatMasker when handling complex mosaic configurations.
- Validation: Performance validated using synthetic benchmark data.
- Performance: Reports improved speed and accuracy relative to TRF and RepeatMasker on benchmark tests.
Scientific Applications:
- Tandem repeat annotation: Precise decomposition of mosaic TRs for improved repeat annotation and characterization.
- Disease association studies: Investigation of genetic underpinnings of diseases linked to extended and mosaic TRs.
- Brain disorder research: Analysis of complex repeat structures associated with various brain disorders.
- Method benchmarking: Benchmarking and comparison of TR decomposition methods using synthetic data.
Methodology:
Performs computational decomposition of mosaic tandem repeats from long-read sequencing reads using an efficient algorithm and validates results by comparison to TRF and RepeatMasker on synthetic benchmark data.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- C, C++
- Added:
- 11/10/2023
- Last Updated:
- 11/10/2023
Operations
Publications
Masutani B, Kawahara R, Morishita S. Decomposing mosaic tandem repeats accurately from long reads. Bioinformatics. 2023;39(4). doi:10.1093/bioinformatics/btad185. PMID:37039842. PMCID:PMC10118999.
PMID: 37039842
PMCID: PMC10118999
Funding: - Japan Agency for Medical Research and Development: 21tm0424219h0001